Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
36,999,749
Share change
-366,937
Total reported value
$4,315,367,902
Put/Call ratio
72%
Price per share
$116.63
Number of holders
349
Value change
+$55,229,563
Number of buys
189
Number of sells
142

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q1 2025

As of 31 Mar 2025, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 349 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,999,749 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., RTW INVESTMENTS, LP, BVF INC/IL, FMR LLC, MACQUARIE GROUP LTD, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Invesco Ltd., and Fairmount Funds Management LLC. This page lists 350 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.